Compare · CNC vs PSNL
CNC vs PSNL
Side-by-side comparison of Centene Corporation (CNC) and Personalis Inc. (PSNL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNC and PSNL operate in Medical Specialities (Health Care), so they compete in similar markets.
- CNC is the larger of the two at $34.83B, about 20.5x PSNL ($1.70B).
- Over the past year, CNC is up 94.0% and PSNL is up 51.5% - CNC leads by 42.4 points.
- CNC has been more active in the news (14 items in the past 4 weeks vs 9 for PSNL).
- CNC has more recent analyst coverage (25 ratings vs 16 for PSNL).
- Company
- Centene Corporation
- Personalis Inc.
- Price
- $69.14-1.98%
- $15.65-1.70%
- Market cap
- $34.83B
- $1.70B
- 1M return
- +3.03%
- -3.54%
- 1Y return
- +93.98%
- +51.55%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 14
- 9
- Recent ratings
- 25
- 16
Centene Corporation
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Personalis Inc.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California.
Latest CNC
- Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma
- SEC Form 4 filed by Centene Corporation
- PA Health & Wellness Earns National Recognition Among Top Medicaid Health Plans for Second Consecutive Year
- Centene to Launch Nationwide Gold Card Program for Qualifying Providers
- SEC Form 8-K filed by Centene Corporation
- Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri
- Wellcare Unveils 2027 Medicare Offerings Focused on Affordability and Integrated Care
- Director Tyler Lauren M was granted 482 shares, increasing direct ownership by 15% to 3,698 units (SEC Form 4)
- Director Tanji Kenneth was granted 603 shares, increasing direct ownership by 5% to 13,093 units (SEC Form 4)
- Director Samuels Theodore R. Ii was granted 583 shares, increasing direct ownership by 2% to 25,796 units (SEC Form 4)
Latest PSNL
- SEC Form 425 filed by Personalis Inc.
- SEC Form 8-K filed by Personalis Inc.
- Personalis downgraded by BTIG Research
- Amendment: SEC Form SC 13E3/A filed by Personalis Inc.
- SEC Form CT ORDER filed by Personalis Inc.
- CFO AND COO Tachibana Aaron sold $47,541 worth of shares (2,931 units at $16.22), decreasing direct ownership by 1% to 195,902 units (SEC Form 4) (for withholding tax)
- President and CMO Chen Richard sold $64,848 worth of shares (3,998 units at $16.22), decreasing direct ownership by 2% to 169,882 units (SEC Form 4) to satisfy withholding obligation
- SVP and Chief Legal Officer Moore Stephen Michael sold $33,543 worth of shares (2,068 units at $16.22), decreasing direct ownership by 2% to 90,257 units (SEC Form 4) to satisfy withholding tax
- Chief Executive Officer Hall Christopher M sold $120,985 worth of shares (7,459 units at $16.22), decreasing direct ownership by 3% to 228,527 units (SEC Form 4) (withholding obligation)
- SEC Form SC 13E3 filed by Personalis Inc.